2022 annual financial data
Sunshine Biopharma Inc. 2022 Operating margin
Sunshine Biopharma Inc. 2022 operating margin with verified reported values.
Direct answer
Operating margin was -199.6%.
Operating income was -8,674,031 USD and net income was -26,744,440 USD.
Operating cash flow was -5,248,358 USD.
Get free Sunshine Biopharma Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,345,603 USD
- Operating income
- -8,674,031 USD
- Net income
- -26,744,440 USD
- Operating cash flow
- -5,248,358 USD